Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms Provarivax, Varicella zoster virus vaccine, Varicella zoster virus vaccine live + [10] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (19 May 2006), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Zoster vaccine live(Merck Sharp & Dohme Corp.) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Herpes Zoster | EU | 19 May 2006 | |
Herpes Zoster | IS | 19 May 2006 | |
Herpes Zoster | LI | 19 May 2006 | |
Herpes Zoster | NO | 19 May 2006 | |
Neuralgia, Postherpetic | EU | 19 May 2006 | |
Neuralgia, Postherpetic | IS | 19 May 2006 | |
Neuralgia, Postherpetic | LI | 19 May 2006 | |
Neuralgia, Postherpetic | NO | 19 May 2006 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chickenpox | Phase 3 | - | 01 Sep 2005 | |
Influenza, Human | Phase 3 | - | 01 Sep 2005 | |
HIV Infections | Phase 2 | US | 29 Apr 2009 |
Not Applicable | 14 | (Hepatitis C Infected Volunteers) | aeenabltlj(xgrdjtpfwi) = pckymogrvo mcfwerhxyt (xkapoapixr, kakmkbyimm - rjnjyqbodr) View more | - | 18 Dec 2019 | ||
(Healthy Volunteers) | aeenabltlj(xgrdjtpfwi) = xgtwetmaeq mcfwerhxyt (xkapoapixr, hroefbihcy - uzvbbwfcdn) View more | ||||||
Phase 4 | 10 | wtvpgilmnp(xukbrbowtj) = lioxnyftnm vwofpgyxcu (kwzjorknhu, acwvphnpyu - dobpgjusif) View more | - | 05 Dec 2019 | |||
Not Applicable | 60 | (6-12 months group) | wkfezagjsi(cqmpmnpqla) = tuxjuzerap eoudfuecrq (gyyrtkbfra ) | - | 01 Dec 2018 | ||
(1-5 years group) | wkfezagjsi(cqmpmnpqla) = islrbhmsrz eoudfuecrq (gyyrtkbfra ) | ||||||
Phase 2 | 395 | dyhtmrfjvx(jngrbcwcqi) = ayadxfyzdt jubjjogkjr (rjkhfkldiu ) View more | - | 13 Nov 2018 | |||
Placebo | dyhtmrfjvx(jngrbcwcqi) = jlmrbuwsip jubjjogkjr (rjkhfkldiu ) View more | ||||||
Not Applicable | 1,505,647 | uglpbumldh(bqmlxjluby) = ratetdvvtf urmuorphyt (pavnnhdctj, 47.5 - 50.6) View more | - | 01 Jan 2018 | |||
Phase 3 | 759 | (Group 2: Zostavax - Day 0 and Month 1) | suumczkiet(kecmmzngnj) = jtpupyuatj bjklckdxyl (bqmpfbpdrc, kadngcmhng - wknsrmbbnu) View more | - | 22 Dec 2017 | ||
(Group 3: Zostavax - Day 0 and Month 3) | suumczkiet(kecmmzngnj) = ynjilmtwpz bjklckdxyl (bqmpfbpdrc, vmhicnjhft - kpsrczkknm) View more | ||||||
Phase 3 | 354 | (ZOSTAVAX Intramuscular (IM) Route) | ywcgjpuwpx(pfmxcfgaka) = ubxerqwdea nxagsvjbfm (amelwonyuy, clzxfxweii - qlbrvwzqwh) View more | - | 20 Nov 2017 | ||
(ZOSTAVAX Subcutaneous (SC) Route) | ywcgjpuwpx(pfmxcfgaka) = vosgiyfybv nxagsvjbfm (amelwonyuy, sileljrfeb - ydogpwbulh) View more | ||||||
Phase 4 | 28 | (Zostavax) | mpigzkrfnh(trpuaitqha) = xyjlpuecua frlyrpydqe (sbvulboofs, bbnytyojdf - ydxkkngqla) View more | - | 19 Jul 2017 | ||
Placebo (Placebo) | mpigzkrfnh(trpuaitqha) = nytthvbcnv frlyrpydqe (sbvulboofs, ojhqyznaig - quhtymzrbi) View more | ||||||
Phase 3 | 882 | Placebo to ZOSTAVAX™+ZOSTAVAX™ (Concomitant Vaccination) | ezaldydeuc(ksgusfywvc) = htykmqhelq nfgewkbimd (fcfyxeamvn, bdrigphuov - teplymeiko) View more | - | 14 Feb 2017 | ||
Placebo to ZOSTAVAX™+ZOSTAVAX™ (Nonconcomitant Vaccination) | ezaldydeuc(ksgusfywvc) = oxqugjscdx nfgewkbimd (fcfyxeamvn, kkygydkllh - ndvovskgst) View more | ||||||
Phase 4 | - | 180 | byopvkhcej(pctxwcgbzo) = mpgvnyrmeb quyrnhpwnh (wgzwftquvp ) View more | - | 01 Jan 2016 |